跳至主要内容
临床试验/IRCT20080901001165N48
IRCT20080901001165N48招募中3 期

Investigating the efficacy of Zofa (a herbal medicine) in symptom management of patients with COVID-19

iak pharmaceutical company0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • age equal or more than 18 years;
  • The patient have written consciously and freely consent to participate in the study.
  • Confirmed diagnosis of COVID-19, with Laboratory (RT-PCR) confirmation.
  • Confirmed diagnosis of COVID-19, with lung CT-Scan result, which is typical for COVID-19 pulmonary involvement.
  • The patient has clinical symptom of COVID-19 (dry cough, respiratory distress, fever)
  • Less than 7 days have passed since the onset of symptoms;

排除标准

  • The patient is in another clinical trial at the same time.
  • The patient needs to receive medical care from the intensive care unit

研究者

发起方
iak pharmaceutical company

相似试验